Use of MM-SES-CD Endoscopic Improvement Thresholds Enhances Effect Size Differentiation between Adalimumab vs. Placebo: A Post-hoc Analysis of the EXTEND Trial

The Modified Multiplier of the SES-CD (MM-SES-CD) refines the assessment of endoscopic Crohn's Disease (CD) severity by differentially weighting parameters in the original SES-CD. A threshold of

Saved in:
Bibliographic Details
Published in:Journal of Crohn's and colitis 2024-11
Main Authors: Wong, Emily C L, Dulai, Parambir S, Marshall, John K, Laroux, Stephen, Jairath, Vipul, Reinisch, Walter, Narula, Neeraj
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Modified Multiplier of the SES-CD (MM-SES-CD) refines the assessment of endoscopic Crohn's Disease (CD) severity by differentially weighting parameters in the original SES-CD. A threshold of
ISSN:1873-9946
1876-4479
1876-4479
DOI:10.1093/ecco-jcc/jjae171